September 22, 2009 â Cordis Corp. has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER Sirolimus-Eluting Coronary Stent â the 2.25 mm CYPHER â which is indicated for treatment of coronary blockages in small vessels.
September 22, 2009 â Toshiba America Medical Systems Inc. yesterday introduced Low-Contrast Imaging (LCI) for Toshibaâs Infinix-i systems with mid (12â x 12â) and large (12â x 16â) flat-panel detectors (FPD).
Cerner cardiovascular solutions enable cardiologists to automate functions across the continuum of care. Built upon the unified Cerner Millennium architecture, our solutions unify cardiovascular diagnostic activities, therapeutic interventions and follow-up regimens into a single workflow, integrated with the electronic medical record (EMR).
September 22, 2009 - At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting Royal Philips Electronics today announced that it will integrate the MAQUET âMagnusâ surgical table with Philipsâ cardiovascular X-ray systems to create an efficient âhybrid operating roomâ environment for a full range of minimally-invasive and open surgical procedures.
Siemens' Artis zee family of systems delivers sharply detailed images required for interventional procedures, enhances clarity in 2-D imaging and enables an array of 3-D imaging applications to help enhance clinical decision-making.
September 21, 2009 â W. L. Gore & Associates last week announced that several physicians recently presented interim data from ongoing GORE PROPATEN Vascular Graft studies to clinical audiences at the 2009 annual vascular meeting.
September 21, 2009 â CardiacAssist Inc. announced today that it will showcase transseptal puncture training simulation, developed by Mentice Inc., at its TandemHeartÂź System exhibit in San Francisco at the âTranscatheter Therapeutics (TCT) 2009â Annual Scientific Session next week.
September 21, 2009 â IBA (Ion Beam Applications S.A.), a provider of PET radiopharmaceuticals, and Aposense Ltd., a developer of agents targeting apoptosis (programmed cell death) for molecular imaging and therapy, today announced an exclusive collaboration agreement for commercializing Aposense [18F]âML-10, Aposenseâs novel agent for molecular imaging of apoptosis.
September 21, 2009 - Toshiba America Medical Systems Inc. introduced Low-Contrast Imaging (LCI) for Toshibaâs Infinix-i systems with mid (12 x12-inch) flat and large (12 x16-inch) flat-panel detectors (FPD), and will demonstrate its low-contrast imaging capabilities at this yearâs Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco, Sept. 21 - Sept.
